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Abstract
Background: Treatment of Robin sequence is often either invasive or of unproven effectiveness. The pre-epiglottic
baton plate (PEBP) is a well-studied alternative, yet is not widely applied internationally. We report on a prospective
3-center cohort study investigating this treatment. Based on an agreed protocol, parents of infants with Robin
sequence referred to participating centers were offered enrollment, which involved taking a maxillary cast followed
by endoscopy to fit the plate and sleep studies to monitor its effectiveness. Recordings were centrally analyzed by
sleep specialists blinded to timing and center. Primary outcome was the mixed-obstructive apnea index, defined as
the number of such apneas/h of sleep; secondary outcomes included the desaturation index to <80% pulse
oximeter saturation and weight gain.
Results: Of 75 infants referred, 49 could be included; 1 center failed to perform appropriate sleep studies. Within a
mean hospitalization of 3 weeks, the mixed-obstructive apnea index decreased (median; interquartile range) from
15.9 (6.3–31.5) to 2.3 (1.2–5.4); it decreased further to 0.7 (0.1–2.4) in the 32 infants who had a successful 3-month
follow-up sleep study performed. The desaturation index normalized (from 0.38 (0–2.7) to 0.0 (0–0.1)). Mean
standard deviation score for weight remained unchanged between admission and follow-up, while the proportion
of tube-fed infants decreased from 74 to 14%.
Conclusions: This prospective multi-center cohort study confirms retrospective audits on the effectiveness of PEBP
treatment in improving upper airway obstruction and feeding problems, the main clinical problems of infants with
Robin sequence. International collaboration is required to compare this with other treatment approaches.
Trial registration: Number NCT02266043, Registered 30/09/2014; registered partially retrospectively.
Keywords: Pierre-Robin sequence, Failure to thrive, Upper airway obstruction
Background
Treatment of infants with the Robin sequence (RS), i.e.
with retrognathia, glossoptosis, upper airway obstruction
and optionally cleft palate, is dominated internationally
by either rather invasive procedures, e.g. mandibular dis-
traction osteogenesis, tongue-lip adhesion or mandibular
traction, by bridging the narrow airway through a
tracheostomy, use of a nasopharyngeal tube, or continu-
ous positive airway pressure, or by recommending the
prone position, which is of unclear effectiveness and
fraught with an increased risk of sudden infant death
syndrome [1]. In contrast, more than one third of RS
infants born in Germany are treated with the pre-
epiglottic baton plate (PEBP) according to a recent
survey [2], which is a less invasive yet effective and
comparatively well-studied alternative. This treatment,
however, requires an interdisciplinary team with
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experience in upper airway endoscopy, pediatric sleep
medicine, speech therapy and orthodontics, which is
not easy to accomplish given that RS is a rare disease
affecting only 1:8000–14000 infants [2]. As a result, pub-
lished studies on PEBP treatment are yet from very few
groups [3–5], calling into question the generalizability of
the encouraging study results reported for this approach.
Given this situation, colleagues from 3 centers, already
offering treatment with the PEBP for several years, con-
vened to perform an observational cohort study on the
practicality and effectiveness of this treatment approach
in RS infants referred to their centers.
Methods
With funding from the German Ministry of Research
and Education, orthodontists and neonatologists from
the departments of pediatrics and orthodontics in
Cologne (center 1), Tübingen (center 2) and Würzburg
(center 3) met in November 2012 to harmonize their ap-
proach. In addition, and prior to study onset, 2 pediatri-
cians from center 2 performed an initiation visit to the
other centers to verify that the local infrastructure met
the agreed standards. According to the study protocol,
families of infants <1 year referred to participating cen-
ters were invited to take part in this observational study,
i.e. all received the treatment considered standard of
care in each center, only clinical and growth data as well
as sleep study results were to be collected and analyzed
centrally.
Infants were admitted and monitored in the neonatal
intensive care unit, where they also underwent a multi-
channel baseline cardiorespiratory sleep study (polygra-
phy, PG). Next, infants had a maxillary imprint taken
and a plaster cast was produced which was used for
manufacturing a prototype of the PEBP. Using the cast
as a model, palatal plates were made from hard acrylic
(Forestacryl-Strong-S, Foerster, Pforzheim, Germany),
covering both the palate (including the cleft) and the al-
veolar ridges. Once a prototype of the plate was ready,
infants had an endoscopy to adjust the length and angle
of the velar extension, which reached down to just above
the epiglottis, with the angle of the baton being adjusted
following endoscopy so that it pushed the base of the
tongue sufficiently forward to open the pharynx. Plates
were held in situ with the help of a fixative cream (Cor-
ega Super-Haftcreme; Procter & Gamble, Cincinnati,
OH) and by extraoral wire bows secured on the infant’s
face using adhesive tape (Steri-Strip and Cavilon-No
Sting Barrier Film, Steri-Strip Compound Benzoin Tinc-
ture, 3 M Health Care, St. Paul, MN, USA). Indication
for initiating PEBP treatment was a mixed-obstructive
apnea index (MOAI) >3 [4]. The plate’s effectiveness in
relieving upper airway obstruction was confirmed by fur-
ther sleep studies, with the aim to achieve a MOAI <3.
If this could not be achieved with the original PEBP, or if
endoscopy showed a lateral or circular narrowing of the
pharynx or the tongue compressing the velum against
the posterior pharyngeal wall (i.e., a Sher type 2–4 ob-
struction [6]), either a plate with a steeper angle of the
pharyngeal spur or one that had a perforated tube at-
tached to the spur was used keep the pharyngeal space
open. Infants received the final appliance for at least
48 h before the control sleep study used for this study
was performed.
Treatment was supplemented by stimulation of the
oral musculature, based on the Castillo-Morales®
approach, and feeding training (initially via finger feed-
ing, subsequently by bottle feeding with a nipple that
allows controlling the ease of milk flow during sucking
(Playtex Drop-Ins, Playtex Products, Edgewell, North
Bergen, NY, USA). Infants were discharged from hospital
once they had a MOAI <3 in a repeat sleep study and
parents had demonstrated that they had learned how to
insert, remove and clean the PEBP, which they were ad-
vised to do at least once daily. Follow-up visits including
a sleep study had been planned approximately 3 months
after hospital discharge, but performance of this sleep
study could only be accomplished in center 2 (see
Results). Further follow-up visits were at the discretion
of participating centers, and were usually scheduled in
2–3 monthly intervals until cleft closure was scheduled at
10–12 months of age. Palatal plate treatment was discon-
tinued once infants showed a normal tongue position and
mandibular size (usually at 4–6 months of age). RS chil-
dren are seen in the respective departments of orthodon-
tics on an annual basis until reaching 16–18 years of age.
Sleep studies
Sleep studies were performed using a computerized sys-
tem (Embla N 7000, MedCare, Reykjavik, Iceland). The
study montage comprised the following channels and sen-
sors: chest and abdominal wall movements (respiratory in-
ductive plethysmography, MedCare; Reykjavik, Iceland),
nasal pressure and linearized nasal airflow (nasal prongs
and built-in pressure transducer, MedCare), pulse oxim-
eter saturation and pulse waveform (Radical, Masimo Inc.,
Irvine, USA), electrocardiogram (MedCare) and digital
video via infrared camera (Panasonic; Tokyo, Japan).
Recordings commenced in the evening and lasted for at
least 8 h; all infants were studied in the supine position.
Recordings were manually analyzed, blinded to center
and timing (before/during treatment/at follow-up), by
pediatric sleep specialists from an external reference lab
(Hospital Cologne-Porz) not otherwise involved in this
study. Sleep study variables were classified using standard
criteria [7, 8]. In brief, total sleep time (TST) was deter-
mined from the first 10-min epoch without movement,
artifact or a distorted pulse waveform to the last such 10-
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min epoch; recordings comprising less than 3 h of TST
were repeated during the following night. An apnea was
scored if (i) the amplitude of the nasal airflow fell to <20%
of the average amplitude of the two preceding breaths, (ii)
no airflow was detected at the mouth, and (iii) the event
comprised at least two breath cycles (i.e. approximately
4 s). An obstructive apnea was scored if (i) the above cri-
teria for apnea were fulfilled and (ii) out-of-phase move-
ments of the chest and abdomen were present. A central
apnea was scored if (i) criteria for apnea were fulfilled and
(ii) no chest and abdominal wall movements were present.
Mixed apneas were defined as apneas with both central
and obstructive components, each lasting at least two
breath cycles. The MOAI was calculated as the sum of
mixed and obstructive apneas per hour of TST; central
apneas were not part of the MOAI.
Desaturation events were visually confirmed based on
the pulse waveform signal to exclude spuriously low
values. The number of desaturation events to ≤80% pulse
oximeter saturation was counted and expressed as a desat-
uration index (DI80), defined as events per hour of TST.
Ethics, consent and permissions
Institutional approval was given by each center’s ethics com-
mittee (reference number for Tübingen, the leading IRB:
160/2012BO1) and written informed parental consent ob-
tained from caregivers of each infant enrolled in this study.
Statistical analyses
Primary endpoint was the change in MOAI before vs.
after treatment. Due to non-normally distributed data a
sign-test was used. A p-value <0.05 was considered sta-
tistically significant concerning the primary endpoint.
All other analyses are regarded descriptive. The follow-
ing factors were analyzed for their possible influence on
MOAI change between admission and discharge: gender
(male vs. female), age at admission (≤28d vs. >28d) and
failure-to-thrive (SDS for weight ≤1.28 vs. >1.28). All
analyses were done with statistical software (SAS 9.2 for
Windows; SAS; Heidelberg, Germany).
Results
Between 11/02/2013 and 23/09/2015, 75 patients with
RS < 1 year of age at admission were referred to partici-
pating centers, with 49 (24 boys) being included in this
study: 8 (16%) from center 1 and 41 from center 2.
Unfortunately, the third study center (Würzburg) did
not succeed in setting up and performing sleep studies
according to the agreed standards; thus, with no data on
the primary outcome, no patient from this center could
be included. Patient flow is depicted in Fig. 1; clinical
variables are shown in Table 1. As there was no statisti-
cally significant difference in the primary outcome
between center 1 and 2, results are shown for both
remaining study centers together.
Most infants (43; 88%) had isolated RS; syndromic RS
was suspected in the remaining, with diagnoses includ-
ing yet undefined syndrome (N = 3) and Franceschetti,
Möbius and Emanuel syndrome (1 infant each). Forty-
three (88%) infants had a cleft palate, and 47 (96%) were
clinically assessed as having breathing difficulties upon
admission. Prior to referral, infants had only received
symptomatic treatment (e.g., prone positioning, naso-
pharyngeal tube). Endoscopically, the pharyngeal situ-
ation was classified as a Sher type 1 in the vast majority
of infants (82%). Thus, the type of palatal plate used was
the “classic” PEBP in 43 infants, and a plate with a perfo-
rated tube attached to the spur in 6 infants. In 1 infant,
intermittently treated with the latter device, the MOAI
improved so rapidly that she could be discharged on a
plate without a spur. Most infants (32; 65%) had one plate
fitted during their initial hospital stay, while 10 required 2,
and five 3, different palatal plates. The remaining 2 infants
had 4 and 6, respectively, plates fitted. No infant needed
mechanical ventilation or required a tracheostomy.
Mean duration of hospital stay for orthodontic treat-
ment was 3.0 (SD 2.0) weeks without significant differ-
ences between centers.
Upon admission, 46 of the 49 infants enrolled had an
interpretable initial sleep study; data for the change in
MOAI during hospitalization (the primary outcome)
were available for 41 infants (Table 2). These showed a
median decrease in the MOAI from 15.9 (interquartile
range (IQR), 6.3–31.5) at admission to 2.3 (1.2–5.4) at
discharge, p < 0.0001 (Fig. 2). 3-month follow-up data
were available for 32 infants from Center 2 and showed
a further decline in median MOAI to 0.7 (0.1–2.4). The
DI80 also decreased (Table 2). Secondary analysis re-
vealed no effect of gender (p = 0.1) or age at treatment on-
set (<28 days vs. > 28 days; p = 0.4) on the pre- vs. post-
intervention change in MOAI. Furthermore, the MOAI
did not differ between infants with vs. without failure-to-
thrive at treatment onset (standard deviation score (SDS)
for weight at admission < −1.28 vs. ≥ 1.28; p = 0.5).
69% of infants were discharged without a feeding tube
after initiation of PEBP-treatment with a remarkable dif-
ference between centers (38% at center 1 vs. 76% at cen-
ter 2, p = 0.03). At 3-month follow-up, 2 of 41 infants
treated at center 2, compared to 5 of 8 infants at center
1, still had a feeding tube in place. Mean SDS for weight
between admission and 3-month follow-up remained
nearly unchanged (−0.84 vs –0.87).
Discussion
This prospective longitudinal cohort study confirms the
effectiveness of the PEBP in improving upper airway ob-
struction and weight gain in infants admitted with
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(mostly isolated) RS. Similar to our previous retrospect-
ive and single-center cohort studies, we could now con-
firm that very similar improvements in upper airway
obstruction, i.e. an 85% reduction in median MOAI
within a few days of treatment, are possible in RS infants
recruited prospectively and in 2 different centers. This
was despite the fact that orthodontic staff at center 1 did
not receive any formal training at the more experienced
site, which confirms the ease of use of this minimally in-
vasive orthodontic treatment. Furthermore, treatment
success was ascertained in a setting with unbiased ana-
lysis of sleep studies. As expressed by weight gain along
the original weight trajectory, PEBP treatment also
helped to improve weight gain with mouth feeding: Al-
though only 7 infants (14%) still had a feeding tube in
place at the 3-month follow-up, mean SDS for weight
remained nearly unchanged hence showing remarkably
good weight growth velocity compared to other studies
on infants with RS [9–11]. No infant suffered treatment
failure or required switching to a surgical procedure to
relieve residual airway obstruction, neither during the
initial hospital stay nor at follow-up.
Nonetheless, our study also shows the difficulties in-
volved in setting up and maintaining the multidisciplin-
ary infrastructure required for an objective evaluation of
any RS treatment, which should include repeated upper
airway endoscopies and sleep studies [12]. Thus, despite
considerable efforts, we failed to implement routine
sleep studies in one center, and to perform 3-month
follow-up studies at the other center. These failures may
be characteristic of rare diseases, where it is difficult to
maintain a complex infrastructure if only 2–3 patients/
year are admitted. Here, center 2 was clearly at an ad-
vantage, as approximately 20% of all neonates with RS
born in Germany are referred to this center [2]. None-
theless, although not yet much used internationally, a re-
cent epidemiologic survey showed that the PEBP
approach studied here is already used in more than one
third of RS infants admitted to hospitals in Germany [2].
There was a low proportion of syndromal RS patients in
our cohort, and most had only a type-1 obstruction ac-
cording to Sher [6]. Reasons for this are unclear, but sev-
eral explanations may be considered: (i) most infants were
referred at less than 6 weeks of age, bearing the potential
Fig. 1 Patient Flow through this study. RS-Infants, infants with (Pierre-) Robin sequence; PEBP, pre-epiglottic baton plate. # In 7 infants with mild
degree of upper airway obstruction a palatal plate without a spur was used, in 2 infants a CPAP-device or naso-pharyngeal tube was applied, 1
infant had early tracheostomy. * 1 study center (Würzburg) did not succeed in setting up and performing sleep studies, therefore the 4 patients
referred to this center could not be included in the study
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for more subtle malformations to be overlooked; (ii) there
was no formal standard at either center for the diagnostic
work-up of these infants in the respective departments of
genetics to identify syndromes potentially associated with
RS; (iii) as published data on the effectiveness of PEBP
treatment yet mostly involved infants with isolated RS, it
is possible that there was some selection bias by referring
hospitals, i.e. that infants with syndromal RS were less
likely to be referred. In any case, our present data are only
valid for infants with isolated RS.
Clearly, a controlled study design would have been
preferable. This, however, was impossible in participat-
ing centers, as there was no longer equipoise among
team members. However, we tried everything possible to
minimize other potential sources of bias and thus con-
sider our results valid against a background of studies
performed in patients with rare conditions.
While the effectiveness of PEBP treatment in relieving
upper airway obstruction did not differ between centers,
there were differences in feeding and growth. Although
not formally studied, we hypothesize that the consider-
able experience with high-calorie enteral feeding strat-
egies [13] and orofacial stimulation therapy in center 2
[14] may have contributed to this result.
Contrary to our hypothesis, we could not confirm that
infants starting treatment at an early age had a more
pronounced improvement in MOAI than those starting
beyond the neonatal period. Nonetheless, we consider it
important to know whether PEBP treatment does induce
mandibular catch-up growth, for which the largest po-
tential would be expected in early infancy, and will ad-
dress this in future studies.
Conclusion
In this first prospective and multicenter study on the ef-
fectiveness of PEBP treatment in improving UAO and
weight gain in infants referred for (largely isolated) RS, we
could confirm retrospective and single-center studies that
it does. However, our data allow no comparison to other
treatment approaches such as mandibular distraction
osteogenesis or the nasopharyngeal airway, so no recom-
mendation concerning the best approach is possible. Given
the heterogeneity in treatment approaches to RS seen
world-wide, with strong beliefs held by each team in their
respective approach, we suggest to set up an international
collaboration among national reference centers to define a
common protocol for comparing the effectiveness of each
approach in their patient population, e.g. using sleep stud-
ies and weight charts.
Table 2 Sleep study results
Variable Admissiona Dischargeb Follow-upc












a No data for 3 infants; b no data for 5 infants, p < 0,001 c no data for
17 infants
Fig. 2 Boxplots showing results for the Mixed-Obstructive Apnea
Index as the primary outcome of this study, studied upon admission,
prior to hospital discharge, and at a 3-month follow-up visit
Table 1 Clinical data
Age at admission, mean
(SD; interquartile range) (wk)
5.0 (5.4; 0.0–15.9)
Age at discharge, mean
(SD; interquartile range) (wk)
8.0 (5.6; 1.1–6.1)
Age at follow-up, mean
(SD; range) (wk)
18.6 (6.8; 7.0–36.1)
SDS for weight upon admission,
mean (SD), n = 48
−0.84 (1.10)
SDS for weight at discharge,
mean (SD), n = 49
−0.74 (0.87)
SDS for weight at follow-up,
mean (SD), n = 41
−0.87 (0.96)
SDS for head circumference,
upon admission; mean (SD), n = 49
−0.76 (1.27)
SDS for head circumference,
at discharge; mean (SD), n = 48
−0.70 (1.17)
SDS for head circumference,
at follow-up; mean (SD), n = 38
−0.57 (1.12)
Feeding tube upon admission, N (%) 36 (74%)
Feeding tube at discharge, N (%) 15 (31%)
Feeding tube at follow-up, N (%) 7 (14%)
Type of obstruction
- Sher 1, N
40
- Sher 2, N 4
- Sher 3, N 3
- Not classified, N 2
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DI: Desaturation index; MOAI: Mixed-obstructive apnea index; PEBP: Pre-
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